Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma

Effects of the Hippo Signaling Pathway in Human Gastric Cancer

(2014) Guang-Xi Zhou et al.   Asian Pacific Journal of Cancer Prevention

Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas

(2014) Susan Y. Luo et al.   LUNG CANCER

Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer

(2014) Xu-Yong Lin et al.   TUMOR BIOLOGY

Expression of hippo pathway in colorectal cancer

(2014) Cuiping Zhang et al.   Saudi Journal of Gastroenterology

Evidence for a Tumor Suppressor Role for the Large Tumor Suppressor Genes LATS1 and LATS2 in Human Cancer

(2013) Tian Yu et al.   GENETICS

Underexpression ofLATS1TSG in colorectal cancer is associated with promoter hypermethylation

(2013) Piotr M Wierzbicki   WORLD JOURNAL OF GASTROENTEROLOGY

YAP oncogene overexpression supercharges colon cancer proliferation

(2012) Joseph Avruch et al.   CELL CYCLE

Decreased expression of LATS1 is correlated with the progression and prognosis of glioma

(2012) Tianhai Ji et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenario

(2012) Arshad A. Pandith et al.   TUMOR BIOLOGY

Hippo signaling in oval cells and hepatocarcinogenesis

(2011) Tongsen Zheng et al.   CANCER LETTERS

Pathology of Lung Cancer

(2011) William D. Travis   CLINICS IN CHEST MEDICINE

Mammalian Hippo pathway: from development to cancer and beyond

(2011) Y. Bao et al.   JOURNAL OF BIOCHEMISTRY

Hypermethylation of the large tumor suppressor genes in Japanese lung cancer

(2010) HIDEFUMI SASAKI et al.   Oncology Letters